Jan Stjernswärd

Institut Català d'Oncologia

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Farkas Vánky

Linköping University

Xavier Gómez-Batiste

Universitat de Vic - Universitat Central de Catalunya

Noreen Teoh

Johns Hopkins University

Kenneth Stanley

Harvard University Press

E. Klein

Karolinska Institutet

K. Stanley

Children's Hospital of Philadelphia

Josep Porta-Sales

Universitat Internacional de Catalunya

Mary Isley

Frontier Science & Technology Research Foundation

Ulf Nilsonne

Karolinska University Hospital

Frank D. Ferris

OhioHealth

Cooperative Institutions

Cleveland Clinic

Karolinska Institutet

Memorial Sloan Kettering Cancer Center

World Health Organization - Pakistan

Karolinska University Hospital

Institut Català d'Oncologia

Harvard University

Cornell University

The University of Texas MD Anderson Cancer Center

World Health Organization

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

National policies for cancer pain relief and palliative care

Palliative Medicine (1992)

Jan Stjernswärd Valentin Koroltchouk Noreen Teoh

10.1177/026921639200600402

Cite

Citations (16)

Lebanon

Journal of Pain and Symptom Management (2002)

Michel Daher Hussein Tabari Jan Stjernswärd Walid Ammar Thérèze Abounasr Nabhan

10.1016/s0885-3924(02)00463-3

Cite

Citations (31)

Design, implementation, and evaluation of palliative care programmes and services with a public health WHO perspective

Oxford University Press eBooks (2012)

Xavier Gómez-Batiste José Espinosa M. Pau González-Olmedo Marisa Martínez-Muñoz Cristina Lasmarías

From the 1990s onwards the World Health Organization (WHO) has been proposing palliative care as a key element of health care systems, to be inserted into mainstream planning and organization. Accordingly, WHO Public Health Palliative Care Programmes have been implemented. These programmes are defined as the systematic application of several measures to improve the care of advanced and terminal patients and their families at a population level either at the sector, regional, or national level. This chapter describes the principles, aims, and elements of WHO Public Health Programmes.

Mainstream

Population Health

10.1093/acprof:oso/9780199599400.003.0081

Cite

Citations (1)

Differences in the Tumor-Associated Reactivity of Blood Lymphocytes and Tumor-Draining Lymph Node Cells in Sarcoma Patients 2

JNCI Journal of the National Cancer Institute (1973)

Farkas Vánky Jan Stjernswärd Ulf Nilsonne R. Sundblad

Journal Article Differences in the Tumor-Associated Reactivity of Blood Lymphocytes and Tumor-Draining Lymph Node Cells in Sarcoma Patients Get access Farkas Vánky, Farkas Vánky Department of Tumor Biology, Karolinska Institutet; Radiumhemmet, Department of Orthopedic Surgery, and Department of Surgery, Karolinska Sjukhuset, Stockholm, Sweden Search for other works by this author on: Oxford Academic PubMed Google Scholar Jan Stjernswärd, Jan Stjernswärd Department of Tumor Biology, Karolinska Institutet; Radiumhemmet, Department of Orthopedic Surgery, and Department of Surgery, Karolinska Sjukhuset, Stockholm, Sweden Search for other works by this author on: Oxford Academic PubMed Google Scholar Ulf Nilsonne, Ulf Nilsonne Department of Tumor Biology, Karolinska Institutet; Radiumhemmet, Department of Orthopedic Surgery, and Department of Surgery, Karolinska Sjukhuset, Stockholm, Sweden Search for other works by this author on: Oxford Academic PubMed Google Scholar Rolf Sundblad Rolf Sundblad Department of Tumor Biology, Karolinska Institutet; Radiumhemmet, Department of Orthopedic Surgery, and Department of Surgery, Karolinska Sjukhuset, Stockholm, Sweden Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 51, Issue 1, July 1973, Pages 17–24, https://doi.org/10.1093/jnci/51.1.17 Published: 01 July 1973 Article history Received: 05 December 1972 Accepted: 07 March 1973 Published: 01 July 1973

10.1093/jnci/51.1.17

Cite

Citations (11)

Immunosuppression by carcinogens.

PubMed (1969)

Jan Stjernswärd

Immunosuppression

Source

Cite

Citations (48)

Opioid Availability in Latin America: The Declaration of Florianópolis

Journal of Palliative Care (1994)

Jan Stjernswärd Éduardo Bruera David E. Joranson Silvia Allende‐Pérez Gustavo A. Ovando-Montejo

Declaration

10.1177/082585979401000403

Cite

Citations (12)

Possible Drawback of Radiotherapy: Rational and Experimental Bases of Post-Surgical Therapies

Recent results in cancer research/Recent Results in Cancer Research (1979)

Jan Stjernswärd

Modalities

Subclinical infection

10.1007/978-3-642-81320-7_17

Cite

Citations (0)

Immunodepressive Effect of 3-Methylcholanthrene. Antibody Formation at the Cellular Level and Reaction Against Weak Antigenic Homografts<xref ref-type="fn" rid="FN2">2</xref>

JNCI Journal of the National Cancer Institute (1965)

Jan Stjernswärd

3-Methyldiolanthrene (MCA) administered to mice reduced the number of antibody-producing spleen cells after immunization with sheep erythrocytes measured at a single cellular level. The immuno-depression was rapid and long. Even 2 days after MCA exposure, when test antigen was given, the number of plaque-forming spleen cells (PFC) decreased more than 50 percent. After a single exposure to MCA, the PFC remained depressed for a period corresponding to the latency period prior to the appearance of the MCA-induced sarcomas. This depression of PFC was studied in groups of mice at different intervals between 1 and 20 weeks after MCA administration. Spleen weight and total spleen cell number were reduced, and there was a specific reduction of PFC when expressed as a fraction of the total number of spleen cells. The depression of the cellular immune response was compared with the humoral hemolysing and hemagglutinating antibody response toward a heterologous test antigen, sheep erythrocytes. Impairment of the graft rejection after MCA exposure, tested across a monospecific weak histocompatibility barrier (H-1) by skin grafting, was first demonstrable at the time of tumor appearance. Skingraft survival was not affected during the earlier part of the tumor latency period. The findings are discussed in relation to an earlier suggestion of Prehn and Main that MCA inhibits immunological responses and thereby allows the outgrowth of antigenic neoplastic cells.

10.1093/jnci/35.5.885

Cite

Citations (76)

Introduction: Modification of immunity and carcinogenesis.

PubMed (1972)

Jan Stjernswärd

Source

Cite

Citations (4)

Institution Specific Activities

Recent results in cancer research/Recent Results in Cancer Research (1981)

Kenneth Stanley Jan Stjernswärd Mary Isley